Response to "A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023: A correspondence".
作者信息
Li Huimin, Huang Qing, Zhang Yuan
机构信息
Department of Hematology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
出版信息
Hum Vaccin Immunother. 2024 Dec 31;20(1):2386225. doi: 10.1080/21645515.2024.2386225. Epub 2024 Aug 7.
Abstract
摘要
相似文献
1
Response to "A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023: A correspondence".
Hum Vaccin Immunother. 2024 Dec 31;20(1):2386225. doi: 10.1080/21645515.2024.2386225. Epub 2024 Aug 7.
2
A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023: A correspondence.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2386223. doi: 10.1080/21645515.2024.2386223. Epub 2024 Aug 6.
3
A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2371664. doi: 10.1080/21645515.2024.2371664. Epub 2024 Jul 3.
4
CAR T Cell Therapy for Hematological Malignancies.
Curr Med Sci. 2019 Dec;39(6):874-882. doi: 10.1007/s11596-019-2118-z. Epub 2019 Dec 16.
5
Bibliometric analysis of research trends and active research areas in chimeric antigen receptor T cell therapy for hematologic malignancies.
Int J Clin Pharm. 2024 Feb;46(1):186-194. doi: 10.1007/s11096-023-01670-1. Epub 2023 Dec 12.
6
CAR T-Cell Therapy in Hematological Malignancies.
Int J Mol Sci. 2021 Aug 20;22(16):8996. doi: 10.3390/ijms22168996.
7
CAR-T-Cell Therapy Based on Immune Checkpoint Modulation in the Treatment of Hematologic Malignancies.
Cell Transplant. 2024 Jan-Dec;33:9636897241293964. doi: 10.1177/09636897241293964.
8
CAR T-Cell Therapy in Hematologic Malignancies: A Voyage in Progress.
Clin Pharmacol Ther. 2020 Jan;107(1):112-122. doi: 10.1002/cpt.1674. Epub 2019 Nov 25.
9
Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis.
BMC Cancer. 2022 Jan 24;22(1):98. doi: 10.1186/s12885-021-09102-x.
10
Recent Advances in CAR-T Therapy.
Cancer Control. 2024 Jan-Dec;31:10732748241263713. doi: 10.1177/10732748241263713.
本文引用的文献
1
A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2371664. doi: 10.1080/21645515.2024.2371664. Epub 2024 Jul 3.
2
A commentary on 'Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis'.
Int J Surg. 2024 Jun 1;110(6):3981-3983. doi: 10.1097/JS9.0000000000001258.
3
Bibliometric analysis of worldwide research trends on tumor burden and immunotherapy: a correspondence.
Int J Surg. 2024 May 1;110(5):3088-3090. doi: 10.1097/JS9.0000000000001157.
4
Bibliometric analysis of three-dimensional printing applications in cardiovascular diseases: a correspondence.
Int J Surg. 2024 Feb 1;110(2):1322-1324. doi: 10.1097/JS9.0000000000000929.
5
Ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer: a comparative bibliometric analysis.
Cell Death Discov. 2023 Jul 10;9(1):238. doi: 10.1038/s41420-023-01542-7.
6
The H Index in Perspective.
Acad Radiol. 2017 Feb;24(2):117-118. doi: 10.1016/j.acra.2016.11.016. Epub 2017 Jan 6.
Zotero 插件